Home -> Law Blog Directory -> Intellectual Property Law Blogs -> TinytechIP
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: TinytechIPUS Patent 7409375 - Nanoparticle neural interconnections for independent component analysis
Independent component analysis is a methodology for extracting distinct signals from a mixed signals such as being able to ascertain a single voice in a crowded party. This patent from Knowmtech teaches a system for using nanoparticles in a neural network interconnection system to facilitate such analysis. Claim 1 reads:
1. A system for independent component analysis, comprising:
a feedback mechanism based on a plasticity rule; and
an electro-kinetic induced particle chain forming a neural network, wherein said feedback mechanism and said electro-kinetic induced particle chain is utilized to extract independent components from a data set.
Full post as published by TinytechIP on August 11, 2008 (boomark / email).
Component Hardware Reaches Class Action Settlement
Component Hardware Group Reaches Class Action Settlement
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
HIV Funds
Dallas Independent School District pays $336,000 settlement for misappropriated program funds.
Sony
to Pay $18.5 Million For Patent Infringment

Patent Profile: StemCells Announces Issuance of Human Neural Stem Cell Patent
StemCells gets patent on Enriched central nervous system stem cell and progenitor cell populations
Neuralstem Announces Grant of European Patent for Neural Stem Cells
Competitive Intelligence Using Patent Analysis
Ding! WARF Wins Round 2 As Stem Cell Patent Upheld
USPTO Patent Reexamination Process Is Flawed, Think Tank Says








